D-0512-2026 Class II Ongoing
FDA drug recall D-0512-2026 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 6, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Potential leaks from perforations in bags. The recall status is ongoing. Affected quantity: 37,215 bags.
Recall details
- Product Type
- Drugs
- Report Date
- May 13, 2026
- Initiation Date
- Apr 6, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 37,215 bags
Product description
DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 1.5% DEX. LM/LC, 2L 5PK, Part Number 054-20221, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.
Reason for recall
Lack of Assurance of Sterility: Potential leaks from perforations in bags.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 25CU02007, 25CU02008, 25CU02009
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0512-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026